Fulton Bank’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,181
Closed -$209K 488
2022
Q1
$209K Sell
3,181
-154
-5% -$9.98K 0.01% 489
2021
Q4
$232K Buy
3,335
+118
+4% +$8.58K 0.01% 500
2021
Q3
$224K Buy
3,217
+392
+14% +$30.2K 0.01% 488
2021
Q2
$224K Buy
+2,825
New +$205K 0.01% 470

Other funds holding ATRC

Fulton Bank's ATRC Position: Q2 2022 in Review

Fulton Bank sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 3,181 shares — an estimated $209K sold.

Fulton Bank first reported a position in ATRC in Q2 2021 and held it in 4 quarters. The position peaked at $232K in Q4 2021. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.

  • Fulton Bank reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
  • Fulton Bank sold 3,181 AtriCure shares in Q2 2022, an estimated $209K.
  • Fulton Bank first reported a position in AtriCure in Q2 2021 and held it in 4 quarters.
  • Fulton Bank's AtriCure position peaked at $232K in Q4 2021.
  • 213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.

Based on Fulton Bank's 13F filing for Q2 2022, filed 7 Jul 2022.